Amit Kumar
CIK: 0001191905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Anixa Biosciences Inc
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Oct 30, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.17$16K - Oct 22, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct8K shares at avg. $2.72$22K - Sep 24, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct7K shares at avg. $2.78$19K - Sep 10, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct3K shares at avg. $2.75$8K - Sep 10, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $2.76$14K - Jul 31, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.47$17K - Jul 27, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.44$17K - Jul 27, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct3.2K shares at avg. $3.37$11K - Jul 24, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct3K shares at avg. $3.73$11K - Jul 20, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.46$17K - Jul 10, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.04$15K - Jun 12, 2026ANIX
Anixa Biosciences Inc
Purchase(P)Direct21K shares at avg. $2.50$53K - Jan 5, 2026ANIX
Anixa Biosciences Inc
Award(A)DirectEmployee Stock Option
350K shares- - Oct 30, 2025ANIX
Anixa Biosciences Inc
Exercise(M)Direct200K shares at avg. $2.92$584K - Oct 30, 2025ANIX
Anixa Biosciences Inc
Tax Payment(F)Direct169.4K shares at avg. $4.06$688K - Jul 30, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.16$16K - Jul 11, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct5K shares at avg. $3.15$16K - Jun 4, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct10K shares at avg. $2.85$29K - Jan 15, 2025ANIX
Anixa Biosciences Inc
Purchase(P)Direct43K shares at avg. $2.23$96K - Jan 2, 2025ANIX
Anixa Biosciences Inc
Award(A)DirectEmployee Stock Option
700K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.17 | $15,850 | Direct |
| Oct 22, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 8,000 | $2.72 | $21,760 | Direct |
| Sep 24, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 7,000 | $2.78 | $19,460 | Direct |
| Sep 10, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 3,000 | $2.75 | $8,250 | Direct |
| Sep 10, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $2.76 | $13,800 | Direct |
| Jul 31, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.47 | $17,350 | Direct |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.44 | $17,200 | Direct |
| Jul 27, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 3,188 | $3.37 | $10,744 | Direct |
| Jul 24, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 3,000 | $3.73 | $11,190 | Direct |
| Jul 20, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.46 | $17,300 | Direct |
| Jul 10, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.04 | $15,200 | Direct |
| Jun 12, 2026 | ANIX Anixa Biosciences Inc | Purchase(P) | 21,000 | $2.50 | $52,500 | Direct |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | Award(A) Employee Stock Option | 350,000 | - | - | Direct |
| Oct 30, 2025 | ANIX Anixa Biosciences Inc | Exercise(M) | 200,000 | $2.92 | $584,000 | Direct |
| Oct 30, 2025 | ANIX Anixa Biosciences Inc | Tax Payment(F) | 169,439 | $4.06 | $687,922 | Direct |
| Jul 30, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.16 | $15,800 | Direct |
| Jul 11, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 5,000 | $3.15 | $15,750 | Direct |
| Jun 4, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 10,000 | $2.85 | $28,500 | Direct |
| Jan 15, 2025 | ANIX Anixa Biosciences Inc | Purchase(P) | 43,000 | $2.23 | $95,890 | Direct |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | Award(A) Employee Stock Option | 700,000 | - | - | Direct |
1-20 of 20 transactions
About KUMAR AMIT
KUMAR AMIT (SEC CIK 0001191905) files insider reports with the SEC as Chief Executive Officer of Anixa Biosciences Inc (ANIX).
Signal8 holds 19 ownership filings by KUMAR AMIT, all Form 4s, filed between Jan 3, 2025 and Nov 2, 2026. Those filings report 20 transactions, from Jan 2, 2025 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KUMAR AMIT's filings is in SAN JOSE,, CA.
Recent filings by KUMAR AMIT
- Oct 30, 2026: Open-market purchase of ANIX shares (Form 4, code P).
- Oct 22, 2026: Open-market purchase of ANIX shares (Form 4, code P).
- Sep 24, 2026: Open-market purchase of ANIX shares (Form 4, code P).
- Sep 10, 2026: Open-market purchases of ANIX shares (2 lines, Form 4, code P).
- Jul 31, 2026: Open-market purchase of ANIX shares (Form 4, code P).
Other insiders filing for Anixa Biosciences Inc (ANIX)
- Titterton Lewis H jr, Director
- Baskies Arnold M, Director
- Gottschalk Emily, Director
- Catelani Michael, President, COO & CFO